Tasmea FY27 Record Earnings Guidance Signals Strong Growth Momentum
Tasmea Limited (ASX: TEA) has issued FY27 guidance forecasting Underlying EBITA of AU$202–208 million and NPATA of AU$128–132 million, indicating over 70% year-on-year growth versus FY26. Performance is driven by execution of its twin-pillar strategy of organic growth and programmatic acquisitions, supported by more than 120 Master Service Agreements and recent acquisitions including WorkPac, Maxim Group and JPS Group. Organic growth is expected at 10–15%, underpinned by recurring revenues and demand across key industrial end markets.
Tasmea’s order book is at record levels, supporting strong forward visibility with a AU$1.436 billion revenue pipeline and about 91% of work secured, recurring or tendered. FY26 guidance has been reconfirmed, reflecting operational stability. The company continues to prioritise organic expansion and integration of acquired businesses while excluding unannounced deals from FY27 assumptions, reinforcing disciplined and transparent earnings outlook amid strong industry tailwinds across core Australian infrastructure and resource markets going forward period.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au
x
Daily Dose of Buy, Sell & Hold recommendations before the market opens.
Start Your 7 Days Free Trial Now!
We use cookies to help us improve, promote, and protect our services.
By continuing to use this site, we assume you consent to this.
Read our
Privacy Policy
and
Terms & Conditions
Tasmea FY27 Record Earnings Guidance Signals Strong Growth Momentum
Tasmea Limited (ASX: TEA) has issued FY27 guidance forecasting Underlying EBITA of AU$202–208 million and NPATA of AU$128–132 million, indicating over 70% year-on-year growth versus FY26. Performance is driven by execution of its twin-pillar strategy of organic growth and programmatic acquisitions, supported by more than 120 Master Service Agreements and recent acquisitions including WorkPac, Maxim Group and JPS Group. Organic growth is expected at 10–15%, underpinned by recurring revenues and demand across key industrial end markets.
Tasmea’s order book is at record levels, supporting strong forward visibility with a AU$1.436 billion revenue pipeline and about 91% of work secured, recurring or tendered. FY26 guidance has been reconfirmed, reflecting operational stability. The company continues to prioritise organic expansion and integration of acquired businesses while excluding unannounced deals from FY27 assumptions, reinforcing disciplined and transparent earnings outlook amid strong industry tailwinds across core Australian infrastructure and resource markets going forward period.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au